Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130481
Status:
COMPLETED
Last Update Posted:
2012-03-07
First Post:
2005-08-12
Brief Title:
Pediatric Atorvastatin in Diabetes Intervention Trial PADIT
Sponsor:
University of Florida
Organization:
University of Florida
Study Overview
Official Title:
Pediatric Atorvastatin in Diabetes Intervention Trial PADIT
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if Atorvastatin can improve blood vessel stiffness and blood vessel function in children 10-18 years old with Type 1 and Type 2 diabetes Subjects will receive atorvastatin 20mg or placebo daily for 3 months and will then switch therapies for the next 3 months
Hypothesis Atorvastatin will improve blood vessel function by decreasing arterial stiffness and improving blood flow
Hypothesis Atorvastatin will improve blood vessel function by decreasing arterial stiffness and improving blood flow
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GCRC M-01 RR 000082 | None | None | None |
| Pfizer 2004-0926 | None | None | None |
| DARE 187 | None | None | None |